vs

Side-by-side financial comparison of MAXCYTE, INC. (MXCT) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.

High Roller Technologies, Inc. is the larger business by last-quarter revenue ($6.3M vs $4.8M, roughly 1.3× MAXCYTE, INC.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -200.5%, a 258.8% gap on every dollar of revenue. On growth, High Roller Technologies, Inc. posted the faster year-over-year revenue change (-16.4% vs -20.9%). High Roller Technologies, Inc. produced more free cash flow last quarter ($-90.0K vs $-2.9M).

MaxCyte Inc. is a global biotechnology company focused on developing cell engineering platforms and enabling technologies for cell and gene therapy advancement. Its proprietary non-viral cell modification systems are widely used by pharmaceutical, biotech and life science research entities to develop immunotherapies, gene-edited treatments and next-generation biologic drugs from preclinical research through commercialization.

S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.

MXCT vs ROLR — Head-to-Head

Bigger by revenue
ROLR
ROLR
1.3× larger
ROLR
$6.3M
$4.8M
MXCT
Growing faster (revenue YoY)
ROLR
ROLR
+4.5% gap
ROLR
-16.4%
-20.9%
MXCT
Higher net margin
ROLR
ROLR
258.8% more per $
ROLR
58.4%
-200.5%
MXCT
More free cash flow
ROLR
ROLR
$2.8M more FCF
ROLR
$-90.0K
$-2.9M
MXCT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MXCT
MXCT
ROLR
ROLR
Revenue
$4.8M
$6.3M
Net Profit
$-9.6M
$3.7M
Gross Margin
Operating Margin
-234.5%
1.3%
Net Margin
-200.5%
58.4%
Revenue YoY
-20.9%
-16.4%
Net Profit YoY
9.4%
831.9%
EPS (diluted)
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MXCT
MXCT
ROLR
ROLR
Q4 25
$4.8M
Q3 25
$4.6M
$6.3M
Q2 25
$5.8M
$6.9M
Q1 25
$5.7M
$6.8M
Q4 24
$6.1M
Q3 24
$5.6M
$7.5M
Q2 24
$5.0M
Q1 24
$5.6M
Net Profit
MXCT
MXCT
ROLR
ROLR
Q4 25
$-9.6M
Q3 25
$-12.4M
$3.7M
Q2 25
$-12.4M
$-592.0K
Q1 25
$-10.3M
$-3.3M
Q4 24
$-10.6M
Q3 24
$-11.6M
$-501.0K
Q2 24
$-9.4M
Q1 24
$-9.5M
Operating Margin
MXCT
MXCT
ROLR
ROLR
Q4 25
-234.5%
Q3 25
-307.4%
1.3%
Q2 25
-244.3%
-7.2%
Q1 25
-214.1%
-47.4%
Q4 24
-213.1%
Q3 24
-250.4%
-6.3%
Q2 24
-241.0%
Q1 24
-219.8%
Net Margin
MXCT
MXCT
ROLR
ROLR
Q4 25
-200.5%
Q3 25
-269.7%
58.4%
Q2 25
-212.2%
-8.5%
Q1 25
-178.7%
-48.4%
Q4 24
-175.0%
Q3 24
-205.9%
-6.7%
Q2 24
-188.8%
Q1 24
-170.6%
EPS (diluted)
MXCT
MXCT
ROLR
ROLR
Q4 25
Q3 25
$-0.12
$0.39
Q2 25
$-0.12
$-0.07
Q1 25
$-0.39
Q4 24
Q3 24
$-0.11
$-0.07
Q2 24
$-0.09
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MXCT
MXCT
ROLR
ROLR
Cash + ST InvestmentsLiquidity on hand
$103.0M
$2.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$171.5M
$6.6M
Total Assets
$202.5M
$16.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MXCT
MXCT
ROLR
ROLR
Q4 25
$103.0M
Q3 25
$105.7M
$2.7M
Q2 25
$126.6M
$2.7M
Q1 25
$138.3M
$3.5M
Q4 24
$154.5M
Q3 24
$153.8M
$1.3M
Q2 24
$157.3M
Q1 24
$157.5M
Stockholders' Equity
MXCT
MXCT
ROLR
ROLR
Q4 25
$171.5M
Q3 25
$180.3M
$6.6M
Q2 25
$190.7M
$2.6M
Q1 25
$199.4M
$2.8M
Q4 24
$206.3M
Q3 24
$213.3M
$-779.0K
Q2 24
$221.3M
Q1 24
$226.4M
Total Assets
MXCT
MXCT
ROLR
ROLR
Q4 25
$202.5M
Q3 25
$213.5M
$16.0M
Q2 25
$219.8M
$12.3M
Q1 25
$230.0M
$12.8M
Q4 24
$239.5M
Q3 24
$248.6M
$12.9M
Q2 24
$251.5M
Q1 24
$257.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MXCT
MXCT
ROLR
ROLR
Operating Cash FlowLast quarter
$-2.7M
$-78.0K
Free Cash FlowOCF − Capex
$-2.9M
$-90.0K
FCF MarginFCF / Revenue
-61.0%
-1.4%
Capex IntensityCapex / Revenue
4.8%
0.2%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$-36.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MXCT
MXCT
ROLR
ROLR
Q4 25
$-2.7M
Q3 25
$-7.5M
$-78.0K
Q2 25
$-9.9M
$-840.0K
Q1 25
$-14.4M
$-3.6M
Q4 24
$-7.8M
Q3 24
$-4.4M
Q2 24
$-4.8M
Q1 24
$-10.6M
Free Cash Flow
MXCT
MXCT
ROLR
ROLR
Q4 25
$-2.9M
Q3 25
$-7.8M
$-90.0K
Q2 25
$-10.4M
$-845.0K
Q1 25
$-15.1M
$-3.6M
Q4 24
$-8.0M
Q3 24
$-4.8M
Q2 24
$-5.1M
Q1 24
$-11.4M
FCF Margin
MXCT
MXCT
ROLR
ROLR
Q4 25
-61.0%
Q3 25
-168.5%
-1.4%
Q2 25
-179.2%
-12.2%
Q1 25
-262.3%
-53.5%
Q4 24
-131.6%
Q3 24
-85.5%
Q2 24
-103.3%
Q1 24
-203.6%
Capex Intensity
MXCT
MXCT
ROLR
ROLR
Q4 25
4.8%
Q3 25
6.5%
0.2%
Q2 25
10.0%
0.1%
Q1 25
11.4%
0.2%
Q4 24
2.4%
Q3 24
7.2%
Q2 24
5.9%
Q1 24
14.4%
Cash Conversion
MXCT
MXCT
ROLR
ROLR
Q4 25
Q3 25
-0.02×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MXCT
MXCT

Products$4.2M87%
Other$634.0K13%

ROLR
ROLR

Net Gaming Revenue$4.9M77%
Net Revenue Noncore Services$1.4M23%

Related Comparisons